|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBSCO_on1085170390 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
190209s2019 xx o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OCLCQ
|d UKAHL
|d N$T
|d OCLCO
|d OCLCF
|d OCLCO
|d K6U
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 1084493957
|a 1084674021
|a 1284940348
|
| 020 |
|
|
|a 1773617648
|
| 020 |
|
|
|a 9781773617640
|q (electronic bk.)
|
| 035 |
|
|
|a (OCoLC)1085170390
|z (OCoLC)1084493957
|z (OCoLC)1084674021
|z (OCoLC)1284940348
|
| 050 |
|
4 |
|a RM301.37
|
| 082 |
0 |
4 |
|a 615.5
|2 23
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Gautam, Shraddha.
|
| 245 |
1 |
0 |
|a Cellular Therapy
|
| 260 |
|
|
|a Ashland :
|b Delve Publishing,
|c 2019.
|
| 300 |
|
|
|a 1 online resource (321 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Half Title Page; Title Page; Copyright Page; About the Authors; Table of Contents; List of Figures; List of Tables; Once the Idea, Today the Reality!; Preface; SECTION I: INTRODUCTION; Chapter 1 Immunology and Cellular Therapies: An Overview; 1.1. Historical Developments In Immunology; 1.2. Overview of Immune System; 1.3. Cells of Immune System; 1.4. Antibodies; 1.5. To Tap Immune Cells for Diagnostics and Therapy; 1.6. Recent Advancements in Cellular Therapy; References; SECTION II PRACTICING CELLULAR THERAPIES; Chapter 2 Regulatory Considerations in Practicing Cellular Therapies
|
| 505 |
8 |
|
|a 2.1. Background2.2. Reasons For The Controversies; 2.3. An Approach Towards Regulatory Guidelines of Cellular as Well as Tissue-Based Products; 2.4. Product Factors Affecting Each Area of Concern: An Overview; 2.5. Regulatory Requirements For Minimally and More Than Minimally Manipulated HCT/PS; 2.6. Future Directions; 2.7. Summary; References; Chapter 3 Principles and Processes Required For The Development of Cellular Therapies; 3.1. Introduction; 3.2. The Benefits of Cellular Therapies; 3.3. Defining The Status of Cellular Therapies: Proven/Unproven
|
| 505 |
8 |
|
|a 3.4. Focusing on Unproven Cellular Therapies3.5. Compassionate Use of Cell Therapy: Making The "Unproven" "Proven; 3.6. Requirement And Challenges of Data Generation Associated With Unproven Cellular Therapies; 3.7 Regulatory Concerns; 3.8 Summary; References; SECTION III CELLS AND TISSUES FOR THERAPEUTIC USE FEW CONCEPTS AND CASE STUDIES; Chapter 4 Bioengineering of Cells; 4.1. Bioengineering of Embryonic Stem Cells; 4.2. Bioengineering of Human Fetal Tissue Germ Cells; 4.3. Bioengineering of Extra Embryonic Fetal Tissue Stem Cells; 4.4. Tooth Stem Cell Engineering
|
| 505 |
8 |
|
|a 4.5. Bioengineering of Limbus Stem Cells4.6. Menstrual Blood Cells In Bioengineering; 4.7. Skin Stem Cells And Bioengineering; 4.8. Bioengineering of Hair; 4.9. Summary; References; Chapter 5 Hematopoietic Progenitor Cellular Therapies; 5.1. Introduction; 5.2. Defining Hematopoietic Stem Cells; 5.3. Transplantation Of Hematopoietic Stem Cells: Cell Therapy; 5.4. Umbilical Cord Blood; 5.5. Peripheral Blood For Cell Therapy; 5.6. Case Study: Stem Cells of Bone Marrow Vs. Peripheral Blood as a Comparison: Clinical Trials; 5.7. Summary; References; Chapter 6 Human Mesenchymal Stromal Cells
|
| 505 |
8 |
|
|a 6.1. Introduction6.2. Sources of Mesenchymal Cells; 6.3. Culturing of MSCs; 6.4. Markers of MSCs; 6.5. Long-Term Storage of MSCs; 6.6. Differentiation Ability of MSCs; 6.7. MSCs And Diseases; 6.8. Case Study: Mesenchymal Stem Cells And Porcine Hepatocytes; 6.9. Summary; References; Chapter 7 Pancreatic Islets Cells; 7.1. Introduction; 7.2. Stem Cells; 7.3. Islet Cell Transplants; 7.4. Embryonic Stem (ES) Cells And Induced Pluripotent Stem (IPS) Cells; 7.5. Pluripotent Stem Cell (PSCs) Transplant; 7.6. ES Cell Therapy; 7.7. Cell Therapy Via Adult Stem Cells
|
| 500 |
|
|
|a 7.8. Regeneration of Pancreatic Islets
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Cellular therapy.
|
| 650 |
|
2 |
|a Cell- and Tissue-Based Therapy
|
| 650 |
|
6 |
|a Thérapie cellulaire.
|
| 650 |
|
7 |
|a Cellular therapy
|2 fast
|
| 700 |
1 |
|
|a Priyadarshini, Anjali.
|
| 700 |
1 |
|
|a Pandey, Prerna.
|
| 776 |
0 |
8 |
|i Print version:
|a Gautam, Shraddha.
|t Cellular Therapy.
|d Ashland : Delve Publishing, ©2019
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2013979
|z Texto completo
|
| 938 |
|
|
|a Askews and Holts Library Services
|b ASKH
|n BDZ0044472782
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL5655585
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 2013979
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 16023390
|
| 994 |
|
|
|a 92
|b IZTAP
|
